Related Experiment Video
Updated: Jul 10, 2026

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials
Published on: April 10, 2016
Near-Infrared Spectrometry as a Tool for Screening Meropenem for Quality
James T Isaacs1, Philip J Almeter1,2, Aaron N Hunter1
1Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY 40536.
Abstract:
Meropenem for Injection, USP is a sterile, pyrogen-free, white to pale yellow crystalline powder and is supplied in vials containing sufficient meropenem to deliver 1 g for intravenous administration. The Drug Quality Task Force at the University of Kentucky has found variability in the near-infrared spectra of meropenem samples. The variability was found both within a lot (where one vial from six was 12.0 SDs from the other 5 vials) and between lots of the drug (where 8 vials were >3 SDs from the center of the library, and one of those was 6.1 SDs away from the center of the library). This variability was detected using a statistical analysis of the spectra that included principal component analysis (PCA) and the BEST metric. Inter-lot variability was assessed using a spectral library of 90 meropenem vials obtained from 15 lots of drug from the same manufacturer. The results suggest that the drug may have been manufactured while the manufacturing process was operating outside of a state of process control.
Insights
Variability in near-infrared spectra of meropenem samples was detected both within and between manufacturing lots. This suggests potential issues with the drug
Area of Science:
- Pharmaceutical Science
- Analytical Chemistry
Background:
- Meropenem for Injection, USP is a sterile powder for intravenous administration.
- Ensuring consistent drug quality is critical for patient safety and therapeutic efficacy.
Purpose of the Study:
- To investigate variability in the near-infrared (NIR) spectra of meropenem samples.
- To assess potential deviations in the manufacturing process based on spectral data.
Main Methods:
- Utilized near-infrared spectroscopy to analyze meropenem vials.
- Employed statistical analysis, including principal component analysis (PCA) and the BEST metric.
- Assessed inter-lot variability using a spectral library of 90 meropenem vials from 15 lots.
Main Results:
- Significant variability was observed in NIR spectra, both within individual lots and between different lots.
- One vial showed a deviation of 12.0 standard deviations (SDs) within a lot.
- Eight vials exceeded 3 SDs from the library center between lots, with one being 6.1 SDs away.
Conclusions:
- The detected spectral variability suggests that the meropenem manufacturing process may have operated outside of a state of process control.
- Further investigation into manufacturing controls is warranted to ensure consistent meropenem quality.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12:08Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
Published on: February 14, 2022
Related Concept Videos
Applications of IR Spectroscopy: Overview
Rapid Identification of Pathogens
Automated Microbial Diagnostics